Octreotide, Tamoxifen, and Chemotherapy in Treating Women With Breast Cancer
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combining hormone therapy with chemotherapy may kill more tumor
cells.
PURPOSE: Randomized phase III trial to study the effectiveness of tamoxifen, octreotide, and
chemotherapy in treating women who have stage I or stage II breast cancer.